H — Medical ResearchEIN: 822120760· Ruling Year: 2018

Odylia Therapeutics Inc

Atlanta, Georgia

B-Health Score
47B-

Financial Health Score

8-metric score across financial health, operational efficiency, and resilience. Based on IRS Form 990 filing data.

Average

💰
$571K
Total Revenue
📊
$867K
Total Expenses
🏦
$9.6M
Net Assets
📋
$41K
Total Liabilities

Financial Trends

5-Year Trend Analysis

Financial Health Indicators

Revenue Growth
-48.0%
Year-over-year change (2022 → 2023)
Net Margin
-51.9%
Revenue minus expenses as % of revenue
Working Capital Ratio
11.12
Net assets divided by total expenses
Liabilities-to-Assets
0.4%
Total liabilities as % of total assets

Filing History

6 filings on record
YearRevenueExpensesAssets
2023$570,773↓48%$867,236$9,688,644↓3%
2022$1,098,401↑220%$866,473↑74%$10,021,651↑2%
2021$343,480↑467%$498,271↑8%$9,833,191↓1%
2020$60,528↓95%$460,910↓69%$9,953,134↓3%
2019$1,275,847↓94%$1,465,742↑693%$10,288,470↓50%
2018$20,657,445$184,728$20,473,217

Frequently Asked Questions

What does Odylia Therapeutics Inc do?▼

Odylia Therapeutics Inc is a medical research nonprofit organization based in Georgia. It is classified under NTEE code H41 and is registered as a 501(c) tax-exempt organization with the IRS.

Is Odylia Therapeutics Inc financially healthy?▼

Financial health scoring requires Form 990 filing data. Check back as we process more filings for Odylia Therapeutics Inc.

How much revenue does Odylia Therapeutics Inc generate?▼

Odylia Therapeutics Inc reports $482K in annual revenue and holds $1.6M in total assets, based on IRS filings.

Similar Organizations

Explore more organizations in the Medical Research category, or browse all nonprofits in Georgia.